CVE-2020-14525

Philips Clinical Collaboration Platform Improper Neutralization of Script in Attributes in a Web Page

Description

Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output used as a webpage that is served to other users.

Remediation

Solution:

  • Philips released the Clinical Collaboration Platform patch 12.2.1.5 in June 2020 for web portals to remediate CVE-2020-14525. Philips Clinical Collaboration Platform Version 12.2.5 was released in May 2020 to remediate CVE-2020-14525. Users with questions regarding their specific Philips Clinical Collaboration Platform installations and new release eligibility should contact Philips service support, or regional service support https://www.usa.philips.com/healthcare/solutions/customer-service-solutions , or call 1-877-328-2808, option 4. The Philips advisory and the latest security information for Philips products are available at the Philips product security website https://www.philips.com/productsecurity .

Category

3.5
CVSS
Severity: Low
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.09%
Third-Party Advisory cisa.gov
Affected: Philips Clinical Collaboration Platform
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2020-14525?
CVE-2020-14525 has been scored as a low severity vulnerability.
How to fix CVE-2020-14525?
To fix CVE-2020-14525: Philips released the Clinical Collaboration Platform patch 12.2.1.5 in June 2020 for web portals to remediate CVE-2020-14525. Philips Clinical Collaboration Platform Version 12.2.5 was released in May 2020 to remediate CVE-2020-14525. Users with questions regarding their specific Philips Clinical Collaboration Platform installations and new release eligibility should contact Philips service support, or regional service support https://www.usa.philips.com/healthcare/solutions/customer-service-solutions , or call 1-877-328-2808, option 4. The Philips advisory and the latest security information for Philips products are available at the Philips product security website https://www.philips.com/productsecurity .
Is CVE-2020-14525 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2020-14525 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2020-14525?
CVE-2020-14525 affects Philips Clinical Collaboration Platform.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.